Learn more about CTMC’s progress in accelerating cell therapy development and manufacturing to reach patients faster.
October 5, 2023
Tumor Infiltrating Lymphocytes (TILs): Old news or the next big thing in cell therapy?
December 21, 2022
Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T cell therapy
June 16, 2022
CTMC, Invectys, and MD Anderson announce strategic collaboration for CAR T cell therapy development
June 6, 2022
Endpoints News: Resilience forges JV with MD Anderson, readying new cell therapies for cancer
For Press Inquiries Contact